课题基金 / 基金详情

Mild TBI and Biomarkers of Neurodegeneration

Mild TBI and Biomarkers of Neurodegeneration
轻度 TBI 和神经退行性变的生物标志物
批准号:
8838166
负责人:
ELAINE R. PESKIND
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-04-01 至 2015-03-31

项目摘要

项目成果

ELAINE R. PESKIND的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供): 爆炸装置爆炸效应引起的轻度颅脑损伤是当前伊拉克和阿富汗冲突中士兵、海军陆战队和其他军人的标志性损伤。部署在伊拉克自由行动/持久自由行动(OIF/OEF)的部队所特有的重复性mTBI,可能会对个人、职业和家庭造成毁灭性的后果。记忆力和注意力受损,焦虑、易怒和情绪不稳定增加,睡眠障碍干扰工作和家庭关系,导致严重残疾。除了mTBI的这些直接后果外,冲击波对脑组织的损伤和/或随后的大脑修复效应可能会启动导致神经退化和痴呆的过程。这项建议将应用先进的功能和结构神经影像和脑脊液(CSF)生物标记物来解决以下问题:1)是否有客观的神经影像和脑脊液生物标记物:a)表征冲击性脑损伤的行为表型;b)区分mTBI和战斗创伤后应激障碍(PTSD)?2)反复冲击性脑损伤是否存在长期的认知障碍?如果是,认知障碍是否与神经退行性痴呆的脑脊液生物标志物和遗传危险因素有关?术语“mTBI”在这里指的是一种持续性脑震荡后症状(认知、行为和躯体症状)的综合征,这些症状在导致mTBI的冲击波事件发生数月和数年后继续表现出来。我们的初步神经成像结果显示,在合并mTBI和持续性PCS的OIF/OEF退伍军人中,以前未被发现的结构和功能异常独立于PTSD并存。具体目的1:探讨冲击伤反复轻度创伤性脑损伤(MTBI)合并PCS的临床(神经认知、神经行为)和结构/功能的神经影像特征。具体目标2:确定反复mTBI伴持续PCS的OIF/OEF退伍军人脑脊液生物标记物的变化是否与神经退行性痴呆的发生和发展有关。目的3:探讨神经退行性变的遗传危险因素(载脂蛋白E[APOE]基因多态性和微管相关蛋白tau[MAPT]亚型)对OIF/OEF退伍军人反复脑损伤和持续性PCS患者临床特征、神经影像和脑脊液生物标志物的影响。该提案涉及诊断成像技术的验证和改进的RR&D优先领域,以及针对TBI的后期或长期后果的创新方法。VHA面临着向这一弱势群体提供初级医疗、康复、心理健康和长期护理的巨大负担。确定mTBI的客观神经影像和脑脊液生物标志物,并澄清mTBI中神经退行性痴呆的长期风险,将:1)改善对mTBI的诊断;2)为改善退伍军人的医疗保健提供目标;以及3)允许适当分配有限的医疗保健、补偿和养老金以及社会资源。拟议研究的成功完成很有可能产生短期和长期的临床影响。在24个月内,该项目将产生用于mTBI的客观生物标记物诊断的工具。在4年内,拟议项目的结果将成为合理设计临床试验的证据基础,以治疗mTBI的当前症状并防止进展为神经退行性痴呆障碍。
英文摘要
DESCRIPTION (provided by applicant): Mild traumatic brain injury (mTBI) caused by blast effects of explosive devices is the "signature injury" of soldiers, Marines, and other service members in the current Iraq and Afghanistan conflicts. Repetitive mTBI characteristic of troops deployed to Operation Iraqi Freedom/Operation Enduring Freedom (OIF/OEF), may have devastating personal, professional and domestic consequences. Impairment of memory and concentration, increased anxiety, irritability and mood instability, and sleep disturbance interfere with job and family relationships, producing substantial disability. In addition to these immediate consequences of mTBI, blast trauma damage to brain tissue and/or subsequent brain reparative effects may initiate processes leading to neurodegeneration and dementia. This proposal will apply advanced functional and structural neuroimaging and cerebrospinal fluid (CSF) biomarkers to address the following questions: 1) Are there objective neuroimaging and CSF biomarkers that: a) characterize the behavioral phenotype of blast-induced mTBI; and b) distinguish mTBI from combat trauma posttraumatic stress disorder (PTSD)? 2) Is there long-term cognitive impairment in repetitive blast mTBI and, if so, is cognitive impairment associated with CSF biomarkers of and genetic risk factors for neurodegenerative dementia? The term "mTBI" here is used to denote a syndrome of persistent postconcussive symptoms ([PCS] cognitive, behavioral, and somatic) that continue to be expressed months and years after blast concussion events that produce mTBI. Our preliminary neuroimaging results demonstrate previously unrecognized structural and functional abnormalities independent of comorbid PTSD in OIF/OEF Veterans with mTBI and persistent PCS. Specific Objective 1: To characterize the clinical (neurocognitive, neurologic, behavioral) and structural/functional neuroimaging characteristics of blast trauma repetitive mild traumatic brain injury (mTBI) in OIF/OEF Veterans with PCS. Specific Objective 2: To determine if OIF/OEF Veterans with repetitive mTBI with persistent PCS express CSF biomarker changes associated with the onset and progression of neurodegenerative dementing disorders. Specific Objective 3: To determine the effects of genetic risk factors for neurodegeneration (apolipoprotein E [APOE] polymorphisms and microtubule associated protein tau [MAPT] subhaplotypes) on both clinical characteristics, and neuroimaging and CSF biomarkers in OIF/OEF Veterans with repetitive mTBI and persistent PCS. This proposal addresses the RR&D priority areas of Validation and Refinement of Diagnostic Imaging Technology and Innovative Approaches to Late or Long-Term Consequences of TBI. VHA faces a huge burden of providing primary medical, rehabilitative, mental health and long term care to this vulnerable population. Identification of objective neuroimaging and CSF biomarkers of mTBI and clarification of the long- term risks of neurodegenerative dementias in mTBI will: 1) improve diagnosis of mTBI, 2) provide targets for improving Veterans' health care; and 3) allow appropriate allocation of limited health care, compensation and pension, and social resources. Successful completion of the proposed research has a high likelihood of yielding both short-term and long-term clinical impacts. Within 24 months, the project will yield tools for objective biomarker diagnosis of mTBI. Within 4 years, results from the proposed project will form the evidence base for rational design of clinical trials to treat current symptoms of mTBI and to prevent progression to neurodegenerative dementing disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining the Role of Post-TBI Sleep Disruption in the Development of CTE and Alzheimer's Disease-Related Neuropathology
Mild TBI and Biomarkers of Neurodegeneration
  • 批准号:
    10490311
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2019
  • 负责人:
    ELAINE R. PESKIND
  • 依托单位:
Mild TBI and Biomarkers of Neurodegeneration
  • 批准号:
    10269890
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2019
  • 负责人:
    ELAINE R. PESKIND
  • 依托单位:
Neurobehavior, Neuropathology, and Risk Factors in Alzheimer's Disease
  • 批准号:
    9265401
  • 项目类别:
  • 资助金额:
    $33.25万
  • 财政年份:
    2016
  • 负责人:
    ELAINE R. PESKIND
  • 依托单位:
海外基金